| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/14/2013 | US20130065895 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065893 Imidazole derivatives as aldosterone synthase inhibitors |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065843 Phenolic Compositions Derived From Apple Skin And Uses Thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065828 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| 03/14/2013 | US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor |
| 03/14/2013 | US20130065826 Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 |
| 03/14/2013 | US20130065824 Controlling the texture of high-protein nutritional compositions comprising micellar casein |
| 03/14/2013 | US20130065821 Composition for preventing and improving metabolic syndrome |
| 03/14/2013 | US20130065820 Synthetic myostatin peptide antagonists |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 03/14/2013 | US20130064913 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| 03/14/2013 | US20130064909 Agglomerated oil impregnated psyllium husk |
| 03/14/2013 | US20130064904 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| 03/14/2013 | US20130064887 Pharmaceutical compositions |
| 03/14/2013 | US20130064884 Composition and method for treating ketosis in cows |
| 03/14/2013 | US20130064859 Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease |
| 03/14/2013 | US20130064834 Methods for treating hypercholesterolemia using antibodies to pcsk9 |
| 03/14/2013 | US20130064832 Notch inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
| 03/14/2013 | US20130064825 Methods of treating or preventing cholesterol related disorders |
| 03/14/2013 | US20130064824 Combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064805 Highly functional enzyme having alpha-galactosidase activity |
| 03/14/2013 | US20130064804 BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE |
| 03/14/2013 | CA2847555A1 Materials and methods for modulating immune responses |
| 03/13/2013 | EP2567966A1 Novel ecdysterone synthesis derivative, preparation method and use thereof |
| 03/13/2013 | EP2567959A1 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 03/13/2013 | EP2567957A1 Compounds for the treatment of dyslipidemia and related diseases |
| 03/13/2013 | EP2566880A1 Aromatic-cationic peptides and uses of same |
| 03/13/2013 | EP2566868A1 Pyrrolo [3, 2 -d]pyrimidin-3 -yl derivatives used as activators of ampk |
| 03/13/2013 | EP2566864A2 Pyridazinones as gpr119 agonists |
| 03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
| 03/13/2013 | EP2566860A1 Bicyclic heteroaryl compounds as gpr119 modulators |
| 03/13/2013 | EP2566859A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same |
| 03/13/2013 | EP2566854A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/13/2013 | EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase |
| 03/13/2013 | EP2566502A1 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
| 03/13/2013 | EP2566499A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| 03/13/2013 | EP2566496A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 03/13/2013 | EP2566495A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| 03/13/2013 | EP2566469A1 Combination therapy |
| 03/13/2013 | CN202777131U Suppository for supplementing potassium for anus |
| 03/13/2013 | CN102971320A New azacyclic compounds |
| 03/13/2013 | CN102971313A Novel glucokinase activators and methods of using same |
| 03/13/2013 | CN102971311A Bicyclic heteroaryl compounds as GPR119 modulators |
| 03/13/2013 | CN102971304A GPR119 agonist |
| 03/13/2013 | CN102971297A Method for preparing an intermediate of pitavastatin or of the salt thereof |
| 03/13/2013 | CN102971000A A composition comprising the extract of Physalis alkekengi var francheti Hort as an active ingredient for preventing and treating inflammatory diseases |
| 03/13/2013 | CN102970997A Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance |
| 03/13/2013 | CN102970993A Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis |
| 03/13/2013 | CN102970987A Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 03/13/2013 | CN102964464A Method for extracting and purifying bracteatum polysaccharide with blood sugar regulation activity |
| 03/13/2013 | CN102964459A Lentinan calcium complex, and preparation method and application thereof |
| 03/13/2013 | CN102964452A msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein |
| 03/13/2013 | CN102964354A Thienoimidazole-like derivatives and applications thereof |
| 03/13/2013 | CN102964352A Chiral 2,3-dihydropyrrole[1,2-a] indole derivatives with biological activity and asymmetric synthesizing method thereof |
| 03/13/2013 | CN102964351A Novel pharmaceutical salt of sitagliptin |
| 03/13/2013 | CN102964347A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/13/2013 | CN102964322A Isoflavone or flavonoid aliphatic ether derivates, preparation method and medical application thereof |
| 03/13/2013 | CN102964238A Bipolar trans-carotenoid salt and application thereof |
| 03/13/2013 | CN102961733A Application of seaweed polypeptide in preparing health-care product for reducing blood fat and blood sugar as well as beverage containing polypeptide for reducing blood fat and blood sugar |
| 03/13/2013 | CN102961730A Traditional Chinese medicine composition for treating diabetes |
| 03/13/2013 | CN102961696A Chinese medicinal composition for treating diabetic nephropathy edema |
| 03/13/2013 | CN102961691A Composition for treating diabetes mellitus |
| 03/13/2013 | CN102961671A Pure traditional Chinese medicine compound preparation for treating diabetes mellitus and preparation method thereof |
| 03/13/2013 | CN102961664A Antithrombotic restorative pill medicine composition and application thereof in treatment of II-type diabetes |
| 03/13/2013 | CN102961663A Chinese herbal medicine mixture for treating diabetes |
| 03/13/2013 | CN102961637A Method for extracting and purifying general flavones in corn stigma |
| 03/13/2013 | CN102961596A Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of for traditional Chinese medicine composition |
| 03/13/2013 | CN102961592A Traditional Chinese medicine composition for treating type II diabetes |
| 03/13/2013 | CN102961577A Medicine dispersible tablet for resisting fatigues and losing weight and preparation method thereof |
| 03/13/2013 | CN102961560A Particle for treating food retention |
| 03/13/2013 | CN102961548A Pure traditional Chinese medicine compound preparation for treating hyperlipidemia and preparation method thereof |
| 03/13/2013 | CN102961525A Medicine composition for losing weight and reducing blood lipid in auxiliary manner and oral liquid preparation method thereof |
| 03/13/2013 | CN102961523A Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
| 03/13/2013 | CN102961501A Application of Tianshen capsule in preparation of drug for treating hyperlipidemia |
| 03/13/2013 | CN102961453A Blood lipid-lowering, AS-resisting and platelet aggregation-inhibiting drug and its preparation method |
| 03/13/2013 | CN102961446A Guava infused-bag type traditional Chinese tablet with effect of reducing blood sugar and processing method thereof |
| 03/13/2013 | CN102961445A Medicinal composition for assisting to reduce blood fat and blood pressure and capsule preparation method thereof |
| 03/13/2013 | CN102961436A Method for rapidly extracting pueraria isoflavones from pueraria waste |
| 03/13/2013 | CN102961435A Medicinal composition for assisting to reduce blood sugar and preparation method thereof |
| 03/13/2013 | CN102961427A Wild chrysanthemum extraction process and measuring method for total flavonoids in wild chrysanthemums |
| 03/13/2013 | CN102961418A Compound Hippophae rhamnoides dipyridamole tablet and preparation method thereof |
| 03/13/2013 | CN102961415A Application of phellinus lonicericola or extract thereof |
| 03/13/2013 | CN102961397A Pharmaceutical composition of fat emulsion injection and compound amino acid injection |
| 03/13/2013 | CN102961388A Medicine capable of promoting secretion of glp-1 and restraining secretion of gip |
| 03/13/2013 | CN102961378A Compound alpha-keto acid tablets and preparation method and detection method thereof |
| 03/13/2013 | CN102961377A Method for preparing compound amino acid injection liquid (20AA) |
| 03/13/2013 | CN102961375A AMPK (Adenosine Monophosphate Activated Protein Kinase) activating agent and application thereof in preparation of medicaments for treating diabetes mellitus and/or diabetic complication |
| 03/13/2013 | CN102961372A Application of danshinolic acid B in inhibition of islet amyloid polypeptide aggregation and treatment of diabetes |
| 03/13/2013 | CN102961363A Potassium chloride slow release capsule |
| 03/13/2013 | CN102961353A Glipizide sustained-release dropping pill for treating diabetes and preparation method thereof |
| 03/13/2013 | CN102961348A Preparation method of gliclazide-containing medicament for treating diabetes mellitus |